DEVICE · Unmapped registry intervention
Intermittent theta-burst stimulation (iTBS) using PowerMAG 100 ppTMS
Find medicine records ·
Find other trials using this name
Clinical trial
IMPACT-D+: Immune-Modulating and Psychometric Effects of Accelerated TMS in Depression Plus Comorbid Post-COVID-19 Condition
NCT07197138
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedIMPACT-D+: Immune-Modulating and Psychometric Effects of Accelerated TMS in Depression Plus Comorbid Post-COVID-19 Condition
Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Post-Acute COVID-19 Syndromeunresolved
Interventions
Sponsors & collaborators
Max-Planck-Institute of Psychiatrylead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07197138 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.